Market open
Baxter/$BAX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Baxter
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
Ticker
$BAX
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
60,000
Website
Baxter Metrics
BasicAdvanced
$15B
Market cap
137.42
P/E ratio
$0.21
EPS
0.57
Beta
$1.16
Dividend rate
2.33%
Dividend yield
Price and volume
Market cap
$15B
Beta
0.57
52-week high
$44.01
52-week low
$28.62
Average daily volume
4.8M
Dividend rate
$1.16
Financial strength
Current ratio
1.43
Quick ratio
0.517
Long term debt to equity
134.676
Total debt to equity
166.129
Dividend payout ratio (TTM)
546.30%
Interest coverage (TTM)
3.73%
Management effectiveness
Return on assets (TTM)
3.20%
Return on equity (TTM)
1.63%
Valuation
Price to earnings (TTM)
137.416
Price to revenue (TTM)
0.985
Price to book
1.89
Price to tangible book (TTM)
-4.44
Price to free cash flow (TTM)
37.956
Dividend yield (TTM)
3.97%
Forward dividend yield
2.33%
Growth
Revenue change (TTM)
32.37%
Earnings per share change (TTM)
-95.85%
3-year revenue growth (CAGR)
6.55%
3-year earnings per share growth (CAGR)
-55.28%
3-year dividend per share growth (CAGR)
3.38%
What the Analysts think about Baxter
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Baxter stock.
Baxter Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Baxter Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Baxter News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market open
Upcoming events
Jan
2
Baxter
Dividend·Payment
$0.17
Per share
FAQs
What’s the current market cap for Baxter stock?
Baxter (BAX) has a market cap of $15B as of December 30, 2024.
What is the P/E ratio for Baxter stock?
The price to earnings (P/E) ratio for Baxter (BAX) stock is 137.42 as of December 30, 2024.
Does Baxter stock pay dividends?
Yes, the Baxter (BAX) stock pays dividends to shareholders. As of December 30, 2024, the dividend rate is $1.16 and the yield is 2.33%. Baxter has a payout ratio of 546.3% on a trailing twelve-month basis.
When is the next Baxter dividend payment date?
The next Baxter (BAX) dividend payment is scheduled for January 02, 2025.
What is the beta indicator for Baxter?
Baxter (BAX) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.